{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:25:44Z","timestamp":1790983544692,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03678"],"award-info":[{"award-number":["19H03678"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K22643"],"award-info":[{"award-number":["19K22643"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although disturbed phosphate metabolism frequently accompanies chronic kidney disease (CKD), its causal role in CKD progression remains unclear. It is also not fully understood how excess salt induces organ damage. We here show that urinary phosphate-containing nanoparticles promote kidney injury in salt-sensitive hypertension. In Dahl salt-sensitive rats, salt loading resulted in a significant\u00a0increase in urinary phosphate excretion without altering serum phosphate levels. An intestinal phosphate binder sucroferric oxyhydroxide attenuated renal inflammation and proteinuria in this model, along with the suppression of phosphaturia. Using cultured proximal tubule cells, we confirmed direct pathogenic roles of phosphate-containing nanoparticles in renal tubules. Finally, transcriptome analysis revealed a potential role of complement C1q in renal inflammation associated with altered phosphate metabolism. These data demonstrate that increased phosphate excretion promotes renal inflammation in salt-sensitive hypertension and suggest a role of disturbed phosphate metabolism in the pathophysiology of hypertensive kidney disease and high salt-induced kidney injury.<\/jats:p>","DOI":"10.1038\/s42003-020-01298-1","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T06:07:55Z","timestamp":1602742075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Urinary phosphate-containing nanoparticle contributes to inflammation and kidney injury in a salt-sensitive hypertension rat model"],"prefix":"10.1038","volume":"3","author":[{"given":"Qin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifuru","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0018-7269","authenticated-orcid":false,"given":"Makoto","family":"Kuro-O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6868-0626","authenticated-orcid":false,"given":"Shigeru","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"1298_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","volume":"15","author":"M Kuro-O","year":"2019","unstructured":"Kuro-O, M. The Klotho proteins in health and disease. Nat. Rev. Nephrol. 15, 27\u201344 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"1298_CR2","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.2215\/CJN.04430415","volume":"10","author":"M Wolf","year":"2015","unstructured":"Wolf, M. Mineral (mal)adaptation to kidney disease\u2013Young Investigator Award Address: American Society of Nephrology Kidney Week 2014. Clin. J. Am. Soc. Nephrol. 10, 1875\u20131885 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1298_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2016.03.039","volume":"90","author":"H Komaba","year":"2016","unstructured":"Komaba, H. & Fukagawa, M. Phosphate-a poison for humans? Kidney Int. 90, 753\u2013763 (2016).","journal-title":"Kidney Int."},{"key":"1298_CR4","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser, D. et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J. Am. Soc. Nephrol. 18, 2600\u20132608 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR5","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova, T. et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305, 2432\u20132439 (2011).","journal-title":"JAMA"},{"key":"1298_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1681\/ASN.2014020218","volume":"26","author":"CM Rebholz","year":"2015","unstructured":"Rebholz, C. M. et al. Serum fibroblast growth factor-23 is associated with incident kidney disease. J. Am. Soc. Nephrol. 26, 192\u2013200 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1681\/ASN.2014060621","volume":"26","author":"M Wolf","year":"2015","unstructured":"Wolf, M. The biomarker niche for fibroblast growth factor 23 testing in CKD. J. Am. Soc. Nephrol. 26, 7\u20139 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR8","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224\u20132260 (2012).","journal-title":"Lancet"},{"key":"1298_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney, P. M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217\u2013223 (2005).","journal-title":"Lancet"},{"key":"1298_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.ajkd.2017.12.014","volume":"72","author":"JD Schold","year":"2018","unstructured":"Schold, J. D. et al. Residential area life expectancy: association with outcomes and processes of care for patients with ESRD in the United States. Am. J. Kidney Dis. 72, 19\u201329 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"1298_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","volume":"104","author":"RP Lifton","year":"2001","unstructured":"Lifton, R. P., Gharavi, A. G. & Geller, D. S. Molecular mechanisms of human hypertension. Cell 104, 545\u2013556 (2001).","journal-title":"Cell"},{"key":"1298_CR12","doi-asserted-by":"publisher","first-page":"b4567","DOI":"10.1136\/bmj.b4567","volume":"339","author":"P Strazzullo","year":"2009","unstructured":"Strazzullo, P., D\u2019Elia, L., Kandala, N. B. & Cappuccio, F. P. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 339, b4567 (2009).","journal-title":"BMJ"},{"key":"1298_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa1311989","volume":"371","author":"A Mente","year":"2014","unstructured":"Mente, A. et al. Association of urinary sodium and potassium excretion with blood pressure. N. Engl. J. Med. 371, 601\u2013611 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1298_CR14","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/S0140-6736(97)05189-1","volume":"350","author":"A Morimoto","year":"1997","unstructured":"Morimoto, A. et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 350, 1734\u20131737 (1997).","journal-title":"Lancet"},{"key":"1298_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/01.HYP.37.2.429","volume":"37","author":"MH Weinberger","year":"2001","unstructured":"Weinberger, M. H., Fineberg, N. S., Fineberg, S. E. & Weinberger, M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 37, 429\u2013432 (2001).","journal-title":"Hypertension"},{"key":"1298_CR16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S0895-7061(00)00253-3","volume":"13","author":"A Bihorac","year":"2000","unstructured":"Bihorac, A., Tezcan, H., Ozener, C., Oktay, A. & Akoglu, E. Association between salt sensitivity and target organ damage in essential hypertension. Am. J. Hypertens. 13, 864\u2013872 (2000).","journal-title":"Am. J. Hypertens."},{"key":"1298_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2215\/CJN.06080809","volume":"5","author":"K Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh, K. et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 519\u2013530 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1298_CR18","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1172\/JCI43124","volume":"121","author":"S Shibata","year":"2011","unstructured":"Shibata, S. et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J. Clin. Investig. 121, 3233\u20133243 (2011).","journal-title":"J. Clin. Investig."},{"key":"1298_CR19","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1681\/ASN.2004090804","volume":"16","author":"JC Aldigier","year":"2005","unstructured":"Aldigier, J. C., Kanjanbuch, T., Ma, L. J., Brown, N. J. & Fogo, A. B. Regression of existing glomerulosclerosis by inhibition of aldosterone. J. Am. Soc. Nephrol. 16, 3306\u20133314 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR20","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","volume":"89","author":"M Nagata","year":"2016","unstructured":"Nagata, M. Podocyte injury and its consequences. Kidney Int. 89, 1221\u20131230 (2016).","journal-title":"Kidney Int."},{"key":"1298_CR21","first-page":"899","volume":"136","author":"E Yaoita","year":"1990","unstructured":"Yaoita, E., Kawasaki, K., Yamamoto, T. & Kihara, I. Variable expression of desmin in rat glomerular epithelial cells. Am. J. Pathol. 136, 899\u2013908 (1990).","journal-title":"Am. J. Pathol."},{"key":"1298_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","volume":"49","author":"S Shibata","year":"2007","unstructured":"Shibata, S., Nagase, M., Yoshida, S., Kawachi, H. & Fujita, T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 49, 355\u2013364 (2007).","journal-title":"Hypertension"},{"key":"1298_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneph.2014.114","volume":"10","author":"XM Meng","year":"2014","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. Inflammatory processes in renal fibrosis. Nat. Rev. Nephrol. 10, 493\u2013503 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"1298_CR24","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1172\/JCI36150","volume":"118","author":"SD Ricardo","year":"2008","unstructured":"Ricardo, S. D., van Goor, H. & Eddy, A. A. Macrophage diversity in renal injury and repair. J. Clin. Investig. 118, 3522\u20133530 (2008).","journal-title":"J. Clin. Investig."},{"key":"1298_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneph.2014.170","volume":"10","author":"NM Rogers","year":"2014","unstructured":"Rogers, N. M., Ferenbach, D. A., Isenberg, J. S., Thomson, A. W. & Hughes, J. Dendritic cells and macrophages in the kidney: a spectrum of good and evil. Nat. Rev. Nephrol. 10, 625\u2013643 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"1298_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/sj.ki.5002091","volume":"71","author":"KN Lai","year":"2007","unstructured":"Lai, K. N., Leung, J. C., Chan, L. Y., Guo, H. & Tang, S. C. Interaction between proximal tubular epithelial cells and infiltrating monocytes\/T cells in the proteinuric state. Kidney Int. 71, 526\u2013538 (2007).","journal-title":"Kidney Int."},{"key":"1298_CR27","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1046\/j.1523-1755.2000.00311.x","volume":"58","author":"T Wada","year":"2000","unstructured":"Wada, T. et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int. 58, 1492\u20131499 (2000).","journal-title":"Kidney Int."},{"key":"1298_CR28","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1046\/j.1523-1755.2000.00309.x","volume":"58","author":"XQ Yu","year":"2000","unstructured":"Yu, X. Q. et al. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Kidney Int. 58, 1469\u20131480 (2000).","journal-title":"Kidney Int."},{"key":"1298_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38389-3","volume":"9","author":"Y Nemoto","year":"2019","unstructured":"Nemoto, Y. et al. Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model. Sci. Rep. 9, 1732 (2019).","journal-title":"Sci. Rep."},{"key":"1298_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19677-4","volume":"8","author":"Y Miura","year":"2018","unstructured":"Miura, Y. et al. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease. Sci. Rep. 8, 1256 (2018).","journal-title":"Sci. Rep."},{"key":"1298_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32065-2","volume":"8","author":"R Santamaria","year":"2018","unstructured":"Santamaria, R. et al. Increased phosphaturia accelerates the decline in renal function: a search for mechanisms. Sci. Rep. 8, 13701 (2018).","journal-title":"Sci. Rep."},{"key":"1298_CR32","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2215\/CJN.09090911","volume":"7","author":"E Lederer","year":"2012","unstructured":"Lederer, E. & Miyamoto, K. Clinical consequences of mutations in sodium phosphate cotransporters. Clin. J. Am. Soc. Nephrol. 7, 1179\u20131187 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1298_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kint.2018.03.024","volume":"94","author":"C Faul","year":"2018","unstructured":"Faul, C. FGF23 effects on the heart-levels, time, source, and context matter. Kidney Int. 94, 7\u201311 (2018).","journal-title":"Kidney Int."},{"key":"1298_CR34","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1152\/ajplegacy.1973.224.5.1143","volume":"224","author":"ZS Agus","year":"1973","unstructured":"Agus, Z. S., Gardner, L. B., Beck, L. H. & Goldberg, M. Effects of parathyroid hormone on renal tubular reabsorption of calcium, sodium, and phosphate. Am. J. Physiol. 224, 1143\u20131148 (1973).","journal-title":"Am. J. Physiol."},{"key":"1298_CR35","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1172\/JCI109415","volume":"63","author":"LD Cowgill","year":"1979","unstructured":"Cowgill, L. D., Goldfarb, S., Lau, K., Slatopolsky, E. & Agus, Z. S. Evidence for an intrinsic renal tubular defect in mice with genetic hypophosphatemic rickets. J. Clin. Investig. 63, 1203\u20131210 (1979).","journal-title":"J. Clin. Investig."},{"key":"1298_CR36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/ki.1995.437","volume":"48","author":"W Prodjosudjadi","year":"1995","unstructured":"Prodjosudjadi, W. et al. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int. 48, 1477\u20131486 (1995).","journal-title":"Kidney Int."},{"key":"1298_CR37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1681\/ASN.2014030226","volume":"26","author":"YJ Jung","year":"2015","unstructured":"Jung, Y. J. et al. SIRT2 regulates LPS-induced renal tubular CXCL2 and CCL2 expression. J. Am. Soc. Nephrol. 26, 1549\u20131560 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cyto.2018.04.025","volume":"110","author":"T Shimodaira","year":"2018","unstructured":"Shimodaira, T. et al. Upregulation of osteopontin expression via the interaction of macrophages and fibroblasts under IL-1b stimulation. Cytokine 110, 63\u201369 (2018).","journal-title":"Cytokine"},{"key":"1298_CR39","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","volume":"95","author":"L Beck","year":"1998","unstructured":"Beck, L. et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl Acad. Sci. USA 95, 5372\u20135377 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1298_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ki.2010.390","volume":"79","author":"AP Sage","year":"2011","unstructured":"Sage, A. P., Lu, J., Tintut, Y. & Demer, L. L. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int. 79, 414\u2013422 (2011).","journal-title":"Kidney Int."},{"key":"1298_CR41","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCRESAHA.111.261479","volume":"111","author":"M Herrmann","year":"2012","unstructured":"Herrmann, M. et al. Clearance of fetuin-A\u2013containing calciprotein particles is mediated by scavenger receptor-A. Circ. Res. 111, 575\u2013584 (2012).","journal-title":"Circ. Res."},{"key":"1298_CR42","doi-asserted-by":"publisher","first-page":"e60904","DOI":"10.1371\/journal.pone.0060904","volume":"8","author":"ER Smith","year":"2013","unstructured":"Smith, E. R., Hanssen, E., McMahon, L. P. & Holt, S. G. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS ONE 8, e60904 (2013).","journal-title":"PLoS ONE"},{"key":"1298_CR43","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.4049\/jimmunol.1002080","volume":"185","author":"DA Fraser","year":"2010","unstructured":"Fraser, D. A. & Tenner, A. J. Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages. J. Immunol. 185, 3932\u20133939 (2010).","journal-title":"J. Immunol."},{"key":"1298_CR44","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"1298_CR45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","volume":"25","author":"C Yin","year":"2019","unstructured":"Yin, C. et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat. Med. 25, 496\u2013506 (2019).","journal-title":"Nat. Med."},{"key":"1298_CR46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bone.2018.02.023","volume":"110","author":"ER Smith","year":"2018","unstructured":"Smith, E. R., Hewitson, T. D., Hanssen, E. & Holt, S. G. Biochemical transformation of calciprotein particles in uraemia. Bone 110, 355\u2013367 (2018).","journal-title":"Bone"},{"key":"1298_CR47","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1681\/ASN.2019010068","volume":"30","author":"L Xu","year":"2019","unstructured":"Xu, L., Sharkey, D. & Cantley, L. G. Tubular GM-CSF promotes late MCP-1\/CCR2-mediated fibrosis and inflammation after ischemia\/reperfusion injury. J. Am. Soc. Nephrol. 30, 1825\u20131840 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26870-y","volume":"8","author":"S Kashyap","year":"2018","unstructured":"Kashyap, S. et al. Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension. Sci. Rep. 8, 8598 (2018).","journal-title":"Sci. Rep."},{"key":"1298_CR49","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1681\/ASN.2018050518","volume":"29","author":"MF Cassini","year":"2018","unstructured":"Cassini, M. F. et al. Mcp1 promotes macrophage-dependent cyst expansion in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 29, 2471\u20132481 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.02101205","volume":"1","author":"S Schwarz","year":"2006","unstructured":"Schwarz, S., Trivedi, B. K., Kalantar-Zadeh, K. & Kovesdy, C. P. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin. J. Am. Soc. Nephrol. 1, 825\u2013831 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1298_CR51","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ki.1980.85","volume":"17","author":"LL Haut","year":"1980","unstructured":"Haut, L. L., Alfrey, A. C., Guggenheim, S., Buddington, B. & Schrier, N. Renal toxicity of phosphate in rats. Kidney Int. 17, 722\u2013731 (1980).","journal-title":"Kidney Int."},{"key":"1298_CR52","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1056\/NEJM200309043491020","volume":"349","author":"S Desmeules","year":"2003","unstructured":"Desmeules, S., Bergeron, M. J. & Isenring, P. Acute phosphate nephropathy and renal failure. N. Engl. J. Med. 349, 1006\u20131007 (2003).","journal-title":"N. Engl. J. Med."},{"key":"1298_CR53","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1681\/ASN.2005050496","volume":"16","author":"GS Markowitz","year":"2005","unstructured":"Markowitz, G. S., Stokes, M. B., Radhakrishnan, J. & D\u2019Agati, V. D. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J. Am. Soc. Nephrol. 16, 3389\u20133396 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR54","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","volume":"53","author":"U Schwarz","year":"1998","unstructured":"Schwarz, U. et al. Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int. 53, 1696\u20131705 (1998).","journal-title":"Kidney Int."},{"key":"1298_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1523-1755.2001.00775.x","volume":"60","author":"V Panichi","year":"2001","unstructured":"Panichi, V. et al. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats. Kidney Int. 60, 87\u201395 (2001).","journal-title":"Kidney Int."},{"key":"1298_CR56","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul, C. et al. FGF23 induces left ventricular hypertrophy. J. Clin. Investig. 121, 4393\u20134408 (2011).","journal-title":"J. Clin. Investig."},{"key":"1298_CR57","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"Singh, S. et al. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int. 90, 985\u2013996 (2016).","journal-title":"Kidney Int."},{"key":"1298_CR58","doi-asserted-by":"publisher","first-page":"F110","DOI":"10.1152\/ajprenal.00379.2017","volume":"315","author":"J van der Wijst","year":"2018","unstructured":"van der Wijst, J. et al. Effects of a high-sodium\/low-potassium diet on renal calcium, magnesium, and phosphate handling. Am. J. Physiol. Ren. Physiol. 315, F110\u2013F122 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1298_CR59","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.4049\/jimmunol.1101749","volume":"187","author":"LT Roumenina","year":"2011","unstructured":"Roumenina, L. T. et al. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance. J. Immunol. 187, 4369\u20134373 (2011).","journal-title":"J. Immunol."},{"key":"1298_CR60","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.152.10.5050","volume":"152","author":"H Jiang","year":"1994","unstructured":"Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W. & Tenner, A. J. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152, 5050\u20135059 (1994).","journal-title":"J. Immunol."},{"key":"1298_CR61","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2012.03.047","volume":"149","author":"AT Naito","year":"2012","unstructured":"Naito, A. T. et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 149, 1298\u20131313 (2012).","journal-title":"Cell"},{"key":"1298_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-O","year":"1997","unstructured":"Kuro-O, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45\u201351 (1997).","journal-title":"Nature"},{"key":"1298_CR63","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/HYPERTENSIONAHA.116.08519","volume":"69","author":"N Xu","year":"2017","unstructured":"Xu, N. et al. Hypokalemia and pendrin induction by aldosterone. Hypertension 69, 855\u2013862 (2017).","journal-title":"Hypertension"},{"key":"1298_CR64","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ajh.2008.301","volume":"21","author":"M Feng","year":"2008","unstructured":"Feng, M. et al. Validation of volume-pressure recording tail-cuff blood pressure measurements. Am. J. Hypertens. 21, 1288\u20131291 (2008).","journal-title":"Am. J. Hypertens."},{"key":"1298_CR65","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata, S. et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat. Med. 14, 1370\u20131376 (2008).","journal-title":"Nat. Med."},{"key":"1298_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1681\/ASN.2008020177","volume":"20","author":"H Segawa","year":"2009","unstructured":"Segawa, H. et al. Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. J. Am. Soc. Nephrol. 20, 104\u2013113 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1298_CR67","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1073\/pnas.1817281116","volume":"116","author":"K Ishizawa","year":"2019","unstructured":"Ishizawa, K. et al. Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin II and regulating renal electrolyte handling. Proc. Natl Acad. Sci. USA 116, 3155\u20133160 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1298_CR68","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/ATVBAHA.108.183384","volume":"29","author":"R Villa-Bellosta","year":"2009","unstructured":"Villa-Bellosta, R. & Sorribas, V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb. Vasc. Biol. 29, 761\u2013766 (2009).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"1298_CR69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbi.2015.06.027","volume":"238","author":"XR Chen","year":"2015","unstructured":"Chen, X. R. et al. Calcium phosphate nanoparticles are associated with inorganic phosphate-induced osteogenic differentiation of rat bone marrow stromal cells. Chem. Biol. Interact. 238, 111\u2013117 (2015).","journal-title":"Chem. Biol. Interact."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-01298-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-01298-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-01298-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:39:02Z","timestamp":1696869542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-01298-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1038\/s42003-020-01298-1","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sucroferric oxyhydroxide (SF) was provided by Kissei Pharma. S.S. received research funding from Kissei Pharma. The company had no role in study design, execution of experiments, decision to publish, or preparation of the manuscript. Y.M. and M.K. have a patent titled \u201cNew calciprotein particle (CPP) measuring method using fluorescent probe\u201d; the patent number is JP6566697 and the publication patent number is JP2016200445A, licensed to Jichi Medical University. All remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"575"}}